NASDAQ:VNET News 24 September 2025

VNET stock jumps nearly 10% as China ADRs rally, with CPI next in focus

VNET shares rose 9.6% to $11.43 in afternoon Nasdaq trading Monday, tracking a 4.2% jump in the Nasdaq Golden Dragon China Index. GDS Holdings gained about 9%. Traders await Tuesday’s U.S. CPI data and bank earnings for signals on rates and market direction. VNET’s next earnings report is scheduled for March 11.

12 January 2026

NASDAQ:GDS·NASDAQ:VNET·Stock Market

GDS Holdings stock jumps nearly 10% as China ADR rally keeps DayOne’s $2 billion funding in focus

GDS Holdings shares jumped 9.8% to $44.98 Monday, tracking a rally in U.S.-listed Chinese stocks after DayOne Data Centers secured over $2 billion in Series C funding. The Nasdaq Golden Dragon China Index rose 4.3%. VNET Group shares gained 9.1%. Traders focused on the financing news and Tuesday’s U.S. inflation report.

12 January 2026

NASDAQ:GDS·NASDAQ:VNET·Stock Market·Technology

VNET stock jumps again as China AI bets build after Goldman’s China call

VNET Group jumped 5% to $10.86 in New York morning trading Friday, extending Thursday’s 10.85% surge. Volume hit 8.5 million shares, more than double Wednesday’s level. The rally tracked renewed interest in China-focused AI and infrastructure stocks. Investors watched for a U.S. Supreme Court tariff decision expected as soon as Friday.

9 January 2026

Artificial Intelligence·NASDAQ:VNET·Stock Market

VNET stock jumps nearly 10% as 21Vianet rides a China tech bid — what traders watch next

VNET Group shares surged 9.8% to $10.22 by midday Thursday, with 3.6 million shares traded after breaking above their 200-day moving average earlier in the week. The rally tracked gains in U.S.-listed China data-center stocks and followed reports of Beijing urging tech firms to halt Nvidia H200 chip orders.

8 January 2026

NASDAQ:GDS·NASDAQ:VNET·Stock Market

VNET Group’s AI-Fueled Data Center Boom Sends Stock Soaring – What Investors Need to Know

Conclusion: VNET Group, Inc. (NASDAQ: VNET) has emerged as a key beneficiary of China’s cloud and AI data center boom, translating surging demand into rapid revenue growth and an eye-popping stock rally. Recent wins like the 40MW hyperscale deal reinforce its credibility, and analysts remain largely bullish, citing strong execution and strategic backing from both tech giants and state-linked investors. However, investors should weigh the breakneck expansion against its high leverage and volatile earnings. VNET’s ascent in the Chinese data center arena – powering everything from cloud services to AI training – positions it for further growth, but prudent management

24 September 2025

Artificial Intelligence·Data Centers·NASDAQ:VNET·Stock Market·Technology Trends

MARA stock jumps 22% into weekend as bitcoin whipsaws; Monday risk test looms

7 February 2026

MARA shares jumped 22.4% to $8.24 Friday, trading higher after hours, as the company moved $87 million in bitcoin to major custodians. About 82.4 million MARA shares changed hands. Bitcoin hovered near $68,928 Saturday. A MARA filing showed its general counsel had shares withheld for taxes on vested stock units, not an open market sale.

GOOG stock price: Alphabet’s $185 billion AI spend plan keeps Google shares on edge into Monday

7 February 2026

Alphabet Class C shares (GOOG) fell 2.48% to $323.10 Friday after the company projected 2026 capital spending of up to $185 billion, more than double 2025 levels. CEO Sundar Pichai sold 32,500 shares earlier in the week under a pre-set plan. The Dow closed above 50,000 for the first time. Over 33.9 million GOOG shares traded, above recent volume.

Apple stock (AAPL) set for Monday test as memory-chip crunch revives iPhone price question

7 February 2026

Apple shares closed up 0.8% at $278.12 Friday, then slipped 0.3% after hours. A global DRAM shortage is raising component costs, putting pressure on Apple’s pricing ahead of its Feb. 24 shareholder meeting. CEO Tim Cook said memory prices will rise “sharply” but gave no details on possible iPhone price hikes. Investors await signals before next week’s U.S. inflation data.

Roivant stock surges on brepocitinib skin-disease data; what to watch into Monday

7 February 2026

Roivant shares surged 22.4% to $25.82 after Phase 2 data showed its drug brepocitinib outperformed placebo in cutaneous sarcoidosis, with no serious adverse events. The company plans a Phase 3 trial in 2026 and has filed for FDA approval in dermatomyositis. Quarterly revenue reached $2 million, with a $313.7 million loss. Cash holdings stood at $4.5 billion.

NASDAQ:VNET News 24 September 2025 - 12 January 2026

VNET stock jumps nearly 10% as China ADRs rally, with CPI next in focus

GDS Holdings stock jumps nearly 10% as China ADR rally keeps DayOne’s $2 billion funding in focus

VNET stock jumps again as China AI bets build after Goldman’s China call

VNET stock jumps nearly 10% as 21Vianet rides a China tech bid — what traders watch next

VNET Group’s AI-Fueled Data Center Boom Sends Stock Soaring – What Investors Need to Know

Stock Market Today

MARA stock jumps 22% into weekend as bitcoin whipsaws; Monday risk test looms

GOOG stock price: Alphabet’s $185 billion AI spend plan keeps Google shares on edge into Monday

Apple stock (AAPL) set for Monday test as memory-chip crunch revives iPhone price question

Roivant stock surges on brepocitinib skin-disease data; what to watch into Monday